- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07625761
Assessment of a New Tool to Measure Tongue Muscle Function (TOM1)
May 28, 2026 updated by: Université Catholique de Louvain
The Iowa Oral Performance Instrument (IOPI) is currently the reference tool for assessing tongue muscle function, measuring the pressure exerted by the tongue on an air-filled bulb.
However, several limitations reduce its precision and clinical relevance.
To overcome these, the TOngue Manometer (TOM) has been developed.
This crossover study compares the two devices in healthy adults, hypothesizing that the TOM's interface will enable participants to produce higher maximal tongue pressure and endurance values, closer to their ground truth.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
58
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Pierre Cnockaert, MSc
- Phone Number: +32478136109
- Email: pierre.cnockaert@outlook.com
Study Locations
-
-
-
Brussels, Belgium, 1200
- Institut de Recherche Expérimentale et Clinique (IREC) - UCLouvain; Lung, Nose, and Skin (LUNS) lab
-
Contact:
- Pierre Cnockaert, MSc
- Email: pierre.cnockaert@outlook.com
-
Principal Investigator:
- Pierre Cnockaert, MSc
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Being a healthy adult aged 18 to 65 years old
- Being able to understand and speak French
Exclusion Criteria:
- Being diagnosed with a cardiorespiratory or neuromuscular disease
- Being diagnosed with obstructive sleep apnea-hypopnea syndrome
- Any reason preventing the participant from completing the measurement protocol (e.g., oral pain, severe cognitive impairment, lack of cooperation, illiteracy)
- Being involved in an oropharyngeal rehabilitation program
- Having dysphagia
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: TOM session
|
New, lab-made device
|
|
Active Comparator: IOPI session
|
The device currently identified as gold standard for tongue muscles assessment
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Tongue Pmax in elevation (pElev)
Time Frame: Throughout the entire study, approximately during 14 months
|
Tongue maximal pressure (kPa) in elevation, either with the TOM or the IOPI, depending on the visit and the randomization order
|
Throughout the entire study, approximately during 14 months
|
|
Tongue endurance in elevation (eElev)
Time Frame: Throughout the entire study, approximately during 14 months
|
Endurance time (sec.),
i.e., time during which the tongue can sustain 50% of its Pmax in elevation, measured either with the TOM or the IOPI, depending on the visit and the randomization order
|
Throughout the entire study, approximately during 14 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Body mass index (kg/m^2)
Time Frame: Throughout the entire study, approximately during 14 months
|
Throughout the entire study, approximately during 14 months
|
|
|
Mouth, tongue, and face assessment test (through MBLF test)
Time Frame: Throughout the entire study, approximately during 14 months
|
This test (MBLF test, for 'test de motricité bucco-linguo-faciale') features an assessment of several muscles (e.g., lips, tongue, and face area) that are assessed on a scale from 0 (no contraction / severe asymmetry) to 3 (normal contraction / complete symmetry).
|
Throughout the entire study, approximately during 14 months
|
|
Mouth breathing questionnaire
Time Frame: Throughout the entire study, approximately during 14 months
|
A score 0-3 suggests high likelihood of habitual nose breathing; 4-7 a suspicion of mouth breathing; 8 or higher a high likelihood of habitual mouth breathing
|
Throughout the entire study, approximately during 14 months
|
|
Tongue thickness (POCUS)
Time Frame: Throughout the entire study, approximately during 14 months
|
A submental and neck ultrasound will be performed to assess tongue muscles thickness (cm)
|
Throughout the entire study, approximately during 14 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: William Poncin, PhD, Université Catholique de Louvain
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 30, 2026
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
December 1, 2027
Study Registration Dates
First Submitted
May 5, 2026
First Submitted That Met QC Criteria
May 28, 2026
First Posted (Actual)
June 4, 2026
Study Record Updates
Last Update Posted (Actual)
June 4, 2026
Last Update Submitted That Met QC Criteria
May 28, 2026
Last Verified
May 1, 2026
More Information
Terms related to this study
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.